Clinical Trials: A Phase II Study of Dasatinib in Patients With Transplant and Non-Transplant Related Unresectable or Metastatic Cutaneous Squamous Cell Carcinoma

Sponsor and Collaborators

Arthur G. James Cancer Hospital & Richard J. Solove Research Institute

National Cancer Institute (NCI)

Contact

Ohio State University Cancer Clinical Trial Matching Service

866-627-7616

osu@emergingmed.com

Clinical Trials Office - Cincinnati Children's Hospital

513-636-2799

Clinical Trials Office - M. D. Anderson Cancer Center

713-792-3245

Principal Investigator

Thomas E. Olencki, DO, Arthur G. James Cancer Hospital & Richard J. Solove Research Institute

ClinicalTrials.gov Identifier

NCT00563290

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs